Clinical Trials Browser

Phase 2 × Unknown × quizartinib × Clear all

NCT03135054 2020-12-10

Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute